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Abstract
At present, targeted radiotherapy (TR) is acknowledged to have great potential in oncology. A large list of interesting
radionuclides is identified, including several radioisotopes of lanthanides, amongst them 145Sm and 153Sm. In this
work the possibility of their production at a cyclotron was investigated using a deuteron beam and a samarium target.
The excitation functions of the natSm(d,x)145,153Sm reactions were determined for deuteron energies up to 50 MeV
using the stacked-foil technique and high-resolution γ-ray spectrometry. The measured cross sections and the con-
tributing reactions were analyzed by comparison with results of the ALICE, EMPIRE and TALYS nuclear reaction
codes. A short overview and comparison of possible production routes is given.
Keywords: deuteron irradiation, natural samarium target, 145Sm, 153Sm, physical yield
1. Introduction
A large number of potential therapeutic radionuclides
that emit low energy (conversion and Auger), inter-
mediate and high energy electrons (-emitters), or α-
particles are known (Beyer, 2000; Neves et al., 2005;
Qaim, 2001; Rosch, 2007; Uusijarvi et al., 2006a,b;
Zalutsky, 2011). Among these, the presently investi-
gated 145Sm is used for brachytherapy (Fairchild et al.,
1987; Gowda et al., 2004; Meigooni and Nath, 1992)
and 153Sm for treatment of bone pain (Bauman et al.,
2005; Finlay et al., 2005; Ramamoorthy et al., 2002).
Both above radioisotopes can be produced through neu-
tron capture on samarium enriched in 144Sm and 152Sm
respectively (IAEA, 2003, 2011). The production yields
are high, but the products are carrier added with mod-
erate specific activity. There is an effort to fulfill
the requirements of nuclear medicine in medical ra-
dioisotope production without relying on nuclear reac-
tors or at least without highly enriched uranium (Laka-
Foundation, 2010; ?). The radio-lanthanides 145Sm and
153Sm can also be produced at accelerators by using
charged particle or photonuclear reactions. In the frame
of our systematic investigation of deuteron induced re-
actions on lanthanides we have measured the activa-
∗Corresponding author: ditroi@atomki.hu
tion cross sections of many long-lived radio-products
induced in samarium targets, among them 145Sm and
153Sm. No earlier experimental data for their excita-
tion functions were found in the literature. The re-
sults for production of 145Sm and 153Sm via deuteron
induced reactions are compared. A discussion of the
different production routes is also presented. Activation
cross sections of the other investigated radioisotopes in
natSm(d,x) reactions will be published separately.
2. Experiment and data evaluation
The activation cross sections of the studied radioiso-
topes (145Eu, 145Sm, 153Sm) were measured, relative
to the 27Al(d,x)22,24Na and natTi(d,x)48V monitor reac-
tions, by using a stacked foil activation technique and
γ-ray spectrometry. More details of the experiment and
the data evaluations are presented in Table 1, while the
decay data used are shown in Table 2. The uncertainty
on each cross-section point was determined in a stan-
dard way (of-Weights-and Measures, 1993) by taking
the square root of the sum of the square of all relative
individual contributions (except the nonlinear time pa-
rameters), supposing equal sensitivities of the different
parameters appearing in the formula. The final uncer-
tainties of the cross-sections contain uncertainties of the
beam current measurement (7 %), the number of target
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Figure 1: The simultaneously re-measured monitor reactions
nuclei (5 %), the determination of activities and conver-
sion to absolute number of the produced nuclei (1-15
%). The absolute values of the cross- sections are esti-
mated to be accurate within 13 %. The uncertainty of
the energy scale was estimated by taking into account
the energy uncertainty of the primary beam (0.3 MeV),
the possible variation in the target thickness and the ef-
fect of beam straggling. The energy uncertainty in the
last foil was estimated to be 1.3 MeV.
3. Model calculations
The updated ALICE-IPPE (Dityuk et al., 1998) and
EMPIRE (Herman et al., 2007) codes (the modified ver-
sions for deuteron induced reactions ALICE-IPPE-D
and EMPIRE-D) were used to analyse the present ex-
perimental results. These modifications were developed
and implemented in the original codes at IPPE and more
details can be found in our previous reports (Hermanne
et al., 2009; Ta´rka´nyi et al., 2007). In these codes a sim-
ulation of direct (d,p) and (d,t) transitions by the general
relations for a nucleon transfer probability in the contin-
uum is included through an energy dependent enhance-
ment factor for the corresponding transitions. The phe-
nomenological enhancement factor is based on system-
atics of experimental data of the related reactions (Ig-
natyuk, 2011). The theoretical data from the TENDL-
2012 (Koning et al., 2012) library (based on the most
recent TALYS code (Koning et al., 2007) were also in-
cluded in the comparison.
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Figure 2: Experimental and theoretical excitation functions for the
natSm(d,xn)145Eu reaction
4. Results
According to Table 1, the 145Sm (T1/2 = 340 d) is
produced directly and through the decay of 145Eu (T1/2
= 5.93 d). Both products were identified in our spec-
tra. Possible contribution from long-lived 145Pm (T1/2 =
17.7 a) can be ignored in this experiment. The situation
is similar for 153Sm (T1/2 = 46.50 h), but in this case the
parent 153Pm (T1/2 = 5.3 min) was not detected due to
the short half-life and the low predicted cross sections.
4.1. Excitation functions
The cross sections for all the reactions studied are
shown in Figures 2 5 and the numerical values are
shown in Table 3. The results for the 40 and 20 MeV
primary incident energies are shown separately to point
out the agreement in the overlapping energy range. The
reactions responsible for the production of the given ac-
tivation products and their Q-values, obtained from the
calculator of the Brookhaven Nat. Lab. (Pritychenko
and Sonzogni, 2003), are given in Table 2.
4.1.1. 145Eu (direct production)
The radioisotope 145Eu (T1/2 = 5.93 d) is formed at
low energies by the 144Sm(d,n) reaction (first maximum)
and by 147−150Sm(d,4-7n) reactions above 20 MeV. The
measured experimental data are shown in Fig. 2, to-
gether with the theoretical predictions. The results in
TENDL-2012 slightly overestimate both the low and
high energy experimental data. The overestimation is
more significant in the case of EMPIRE-D and ALICE-
D.
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Table 1: Main experimental parameters and methods of data evaluation
Parameter Value Data evaluation Method
Reaction natSm(d,x) Gamma spectra evaluation Genie 2000 (Canberra, 2000; Sze´kely,
1985)
Incident particle Deuteron Determination of beam intensity Faraday cup (preliminary)
Fitted monitor reaction (final) (Ta´rka´nyi
et al., 1991))
Method Stacked foil Decay data NUDAT 2.6 (Kinsey et al., 1997),(NuDat,
2011)
Stack composition Ho-Sm-Al-Ti, repeated 27 times Reaction Q-values Q-value calculator (Pritychenko and Son-
zogni, 2003; Audi et al., 2012)
Target and thickness natSm foils, 25.14, 23.13,
24.20 mm
Determination of beam energy Andersen (preliminary) (Andersen and
Ziegler, 1977)
Fitted monitor reaction (final) (Ramamoor-
thy et al., 2002)
Number of target foils
Isotopic abundance
27
144-3.1 %-stable
147-15.0 %-1.06*1011 y 148-11.3 %-7*1015
y
149-13.8 %-7*1015 y
150-7.4 %- stable
152-26.7- stable
154-22.7- stable
Uncertainty of energy cumulative effects of possible uncertainties
Accelerator Cyclone 90 cyclotron of the Universit
Catholique in Louvain la Neuve (LLN)
Cross sections Elemental cross section
Primary energy 50 MeV Uncertainty of cross sections sum in quadrature of all individual contri-
butions (of-Weights-and Measures, 1993)
Irradiation time 66 min Yield Physical yield (Bonardi, 1987)
Beam current 120 nA
Monitor reaction, [recommended val-
ues]
27Al(d,x)24Na
natTi(d,x)48V reactions
(Ta´rka´nyi et al., 2001)
Monitor target and thickness natAl, 98, 49.6 mm
natTi 10.9 mm
detector HPGe
g-spectra measurements 4 series
Cooling times 6 h, 25 h, 70 h, 530 h
4.1.2. 145Sm (cumulative)
The cumulative cross sections for 145Sm (T1/2 = 340
d) production are shown in Fig. 3. In this experi-
ment 145Sm is produced directly via (d,pxn) reactions
and from decay of the shorter-lived 145Eu (T1/2 = 5.93
d) discussed above. The cross sections were deduced
from spectra measured after 5 half-lives of the 145Eu
parent decaying completely with EC to 145Sm (97 %).
The missing part was corrected on the basis of the mea-
sured 145Eu cross sections. As stated earlier, the pos-
sible contribution from the long-lived 145Pm (T1/2 =
17.7 a) can be ignored. The first peak of the excita-
tion function at 10 MeV is the sum of the 144Sm(d,n)
and 144Sm(d,p) reactions. The higher energy part is the
sum of 147−150Sm(d,4-7n) and 147−150Sm(d,p3-6n) reac-
tions. There is a good agreement between the cumu-
lative production of 145Sm and the results of TENDL-
2012 at higher energies. At energies below 15 MeV, as a
result of the known underestimation of (d,p) (Hermanne
et al., 2009; Ta´rka´nyi et al., 2007) and compensation by
overestimation of (d,n) reaction, the TENDL discrep-
ancy is finally only a few percent. In case of ALICE-D
and EMPIRE-D at low energies the description of the
(d,p) is better, but the high energy part is significantly
overestimated.
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Figure 3: Experimental and theoretical excitation functions for
natSm(d,x)145Sm
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Table 2: Decay characteristics of the investigated activation products and Q-values of contributing reactions
Nuclide
Decay path
Half-life Eγ (keV) Iγ (%) Contributing reaction Q-value
(keV)
145Eu
ε: 100 %
5.93 d 653.512
893.73
1658.53
15.0
66
14.9
144Sm(d,n)
147Sm(d,4n)
148Sm(d,5n)
149Sm(d,6n)
150Sm(d,7n)
152Sm(d,9n)
154Sm(d,11n)
1090.5
-20424.02
-28565.4
-34435.74
-42422.43
-56276.58
145Sm
ε: 100 %
340 d 61.2265 12.15 144Sm(d,p)
147Sm(d,p3n)
148Sm(d,p4n)
149Sm(d,p5n)
150Sm(d,p6n)
152Sm(d,p8n)
145Eu decay
145Pm decay
4532.534
-16981.99
-25123.37
-30993.72
-38980.41
-52834.55
1090.5
-15583.55
153Sm
β− : 100 %
46.28 h 103.18012 29.25 152Sm(d,p)
154Sm(d,p2n)
153Pm decay
3643.834
-10191.36
-11320.47
When complex particles are emitted instead of individual protons and neutrons the Q-values have to be decreased by the respective binding
energies of the compound particles: np-d, +2.2 MeV; 2np-t, +8.48 MeV;
n2p-3He, +7.72 MeV; 2n2p-a, +28.30 MeV
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Figure 4: Experimental and theoretical excitation functions for
natSm(d,x)153Sm
4.1.3. 153Sm
The radioisotope 153Sm (T1/2 = 46.50 h) is formed di-
rectly by the 152Sm(d,p) and 154Sm(d,p2n) reactions and
from the decay of short-lived 153Pm (T1/2 = 5.25 min).
The experimental and theoretical results are shown in
Fig. 4. The 153Pm is produced via the 154Sm(d,2pn)
low cross section reaction. The TENDL-2012 data un-
derestimate the (d,p) reaction part and overestimate the
(d,p2n). In case of ALICE-D and EMPIRE-D the agree-
ment for low energy (d,p) part is good, but the (d,p2n)
is underestimated.
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Figure 5: Integral yields for production of 145Eu and 145,153Sm de-
duced from the excitation functions
4.2. Thick target yields
Thick target yields (integrated yield for a given inci-
dent energy down to the reaction threshold) were calcu-
lated from curves fitted to our experimental cross sec-
tion data The results for physical yields (Bonardi, 1987)
are presented in Fig. 5. No earlier experimental thick
target yield data were found in the literature.
5. Comparison of the production routes
The two radio-lanthanides discussed (145,153Sm) can
be produced via various reactions. Among these com-
petitive production routes we discuss below only the
4
Table 3: Measured cross sections of the 145Eu and 145,153Sm reactions and estimated uncertainties
Energy (MeV) 145Eu (mb) 145Sm (mb) 153Sm (mb)
49.2 ± 0.30 143.4 ± 16.10 213.9 ± 24.1 56.7 ± 6.4
47.9 ± 0.33 139.2 ± 15.64 210.9 ± 23.7 59.2 ± 6.7
46.5 ± 0.36 136.8 ± 15.37 207.2 ± 23.3 59.5 ± 6.7
45.1 ± 0.39 138.2 ± 15.51 185.6 ± 20.9 60.8 ± 6.8
43.6 ± 0.42 137.9 ± 15.49 198.4 ± 22.3 64.5 ± 7.2
42.1 ± 0.46 137.9 ± 15.50 178.4 ± 20.1 64.3 ± 7.2
40.6 ± 0.49 134.2 ± 15.08 189.7 ± 21.4 66.0 ± 7.4
39.0 ± 0.52 130.7 ± 14.68 173.9 ± 19.6 67.3 ± 7.6
37.4 ± 0.56 126.6 ± 14.23 157.0 ± 17.7 68.3 ± 7.7
35.7 ± 0.60 117.5 ± 13.21 148.3 ± 16.8 69.4 ± 7.8
34.0 ± 0.63 105.4 ± 11.84 132.4 ± 15.0 69.1 ± 7.8
32.2 ± 0.67 88.5 ± 9.95 109.1 ± 12.3 66.4 ± 7.5
30.3 ± 0.72 70.8 ± 7.96 87.1 ± 9.9 63.0 ± 7.1
28.4 ± 0.76 51.2 ± 5.76 79.0 ± 9.0 59.0 ± 6.6
26.3 ± 0.80 25.6 ± 2.89 33.6 ± 3.9 52.7 ± 5.9
24.1 ± 0.85 5.9 ± 0.67 11.8 ± 1.4 53.3 ± 6.0
21.7 ± 0.90 1.9 ± 0.24 4.9 ± 1.4 42.4 ± 4.8
19.2 ± 0.96 2.4 ± 0.30 7.8 ± 1.1 43.4 ± 4.9
16.3 ± 1.02 3.9 ± 0.46 8.4 ± 1.0 51.1 ± 5.7
14.2 ± 1.07 6.6 ± 0.77 20.9 ± 2.8 53.0 ± 6.0
11.8 ± 1.12 8.2 ± 0.93 15.0 ± 1.7 63.5 ± 7.1
10.3 ± 1.16 7.7 ± 0.88 13.1 ± 1.5 58.9 ± 6.6
9.5 ± 1.17 6.0 ± 0.69 10.8 ± 1.3 49.9 ± 5.6
8.6 ± 1.19 4.1 ± 0.47 7.2 ± 0.8 39.5 ± 4.4
7.6 ± 1.22 2.0 ± 0.23 4.6 ± 0.5 25.0 ± 2.8
6.6 ± 1.24 0.9 ± 0.10 2.3 ± 0.3 13.6 ± 1.5
5.4 ± 1.26 0.3 ± 0.03 6.5 ± 0.7
low energy, light charged particle induced routes, pre-
sented in Table 4 in more detail (Eparticle < 100 MeV).
Table 4 does not contain the 3He induced reactions from
practical reasons, taking into account the availability
and cost of the high intensity 3He irradiations. The re-
lated excitation functions are shown in Figs. 6-11. Ex-
cept for the natSm(p,xn)145Eu-145Sm reaction, investi-
gated by Blue et al. (Blue, 1988) (yields) and the present
data on deuterons, no experimental data are available
for cross sections and yields for charged particle pro-
duction routes. The (n,γ) cross sections and yields
were taken from (Mirzadeh et al., 1992; Pritychenko
and Mughabghab, 2012). For comparison of production
routes of charged particle induced reactions we have
used TTY (thick target yield) derived from the theoret-
ical data of TENDL, ALICE and EMPIRE which are
normalized to the measured experimental data, in case
of existing experimental data. Otherwise, the theoreti-
cal data were selected after comparing with the system-
atics of the experimental data in the same mass region.
As for many practical applications, also for medical iso-
tope production there are several factors determining the
optimal production route. The first group of factors is
connected to requirements in the patient related applica-
tion: level of specific activity, radionuclidic purity, car-
rier added or carrier free product, large scale routine ap-
plication, small scale research work route. The second
group of factors is connected to the technology used:
minimal required production yields, natural or highly
enriched targets, target mass, target cooling problems,
recovery and radioactive waste problems, the available
beam properties (particle type, current, energy), possi-
bility of parallel irradiations, etc. The third group of
factors is determined by the continuously changing day
to day requirements: the new competing radio-products
and application methods, the new regulations and trend
in nuclear technology. Nowadays the largest part of rou-
tinely used therapeutic radioisotopes is produced at nu-
clear research reactors. There is however a significant
effort to transfer the production to accelerators by im-
proving beam characteristics and production technology
and/or introducing new accelerator produced isotopes
with characteristics similar to reactor products.
5.1. Production of 145Sm
According to Table 4, the 144Sm(n,γ)145Sm produc-
tion route is the method of choice from point of view
of yield and irradiation technology if a carrier added,
relatively low specific activity 145Sm end product is sat-
isfactory. The route to get carrier free, high specific ac-
tivity 145Sm is possible only with accelerators through
the decay of 145Eu or through the direct production
from alpha induced nuclear reactions on natural or en-
riched neodymium. Indirect production through 145Eu
obtained from irradiation of Sm targets requires two
chemical separations, while in the case of direct pro-
duction one chemical separation is needed to produce
a high-specific-activity and high radionuclidic purity
145Sm end product. Out of them the 147Sm(p,3n)145Eu-
145Sm and the 147Sm(p,x)145Sm are the most produc-
tive (147Sm 15% in natural) and requires a 30 MeV cy-
clotron (or accelerator). The product is contaminated
with long lived α-emitter 146Sm, but with very low ac-
tivity. The radionuclidic impurity is lower in the case
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Figure 6: Theoretical excitation functions for 147Sm(p,x)145Eu and
145Sm reactions
of the 144Sm(d,n)145Eu-145Sm (144Sm 3.1%, low energy
irradiation to avoid (d,3n) and contamination with long-
lived 143Pm) and 142Nd(α,n)145Sm reactions (low energy
to avoid (α,2n) and (α,3n)). In case of other p-, d-,
and α induced reactions the simultaneously produced
146,147Sm do not cause serious impurity due to their ex-
tremely long half-lives. In all cases highly enriched tar-
gets are required. The excitation functions for the main
reactions based on our ALICE-IPPE, EMPIRE results
and on data in TENDL-2012, are shown in Figs. 6-9.
5.2. Production of 153Sm
According to the Table 4, it is difficult to compete in
efficiency with the production of 153Sm in reactors due
to the large production cross section and also because
the products of the proton and deuteron induced reac-
tions are carrier added. The only way to get a no carrier
added product is through the low yield 150Nd(α,n)153Sm
reaction (5.1% abundance). In all cases highly enriched
targets are required. The proton and deuteron induced
reactions can however have importance for local use due
to the relatively short half-life of 153Sm (T1/2 = 46.50 h)
and due to the unused beam time of charged particle ac-
celerators. The production requires highly enriched tar-
gets. The cross sections of the most important reactions
are shown in Figs. 10-12.
6. Summary and conclusion
From a series of radioisotopes produced in deuteron
induced nuclear reactions on natural samarium the med-
ically important 145Sm and 153Sm as well as 145Eu as
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Table 4: Production routes of 145Sm and 153Sm
Nuclide Reaction σ,σmax (b) Energy range(MeV) Yield (MBq/C) Reference
145Sm 144Sm(n,γ)145Sm 1.64 thermal 200 MBq/mg∗ (Mirzadeh et al., 1992)
145Sm 144Sm(d,n)145Eu-145Sm 0.26 20-8 32 this work (exp)
144Sm(d,x)145Sm 0.68 20-8 97 this work (exp)
147Sm(d,4n)145Eu-145Sm 0.89 50-25 713 TENDL 2012
147Sm(d,x)145Sm 0.99 50-25 914 TENDL 2012
natSm(d,xn)145Eu-145Sm 0.15 50-25 121 this work (exp)
natSm(d,x)145Sm 0.26 50-25 163 this work (exp)
147Sm(p,3n)145Eu-145Sm 1.05 50-20 64854 this work(EMPIRE)
147Sm(p,x)145Sm 1.18 50-20 81906 this work(EMPIRE)
142Nd(α,n)145Sm 0.31 24-14 289 this work(ALICE)
143Nd(a,2n)145Sm 1.05 35-19 2500 this work(ALICE)
153Sm 152Sm(n,γ)153Sm 206 thermal 105 MBq/mg∗ ,# (Mirzadeh et al., 1992)
153Sm 152Sm(d,p)153Sm 0.25 24-7 10057 this work, (exp+ EMPIRE)
154Sm(d,p2n)153Sm 0.3 50-20 54639 this work (exp+EMPIRE)
154Sm(p,pn)153Sm 0.14 100-20 145550 this work(EMPIRE)
natSm(p,pxn)153Sm 0.031 100-20 47480 this work(EMPIRE)
150Nd(α,n)153Sm 0.020 40-15 66 this work (EMPIRE)
∗ irradiation time = half-life; neutron flux = 1.1014 n/cm2/s; 100 % enriched target
# irradiation time = 180 d
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action
parent of 145Sm were selected for detailed study. Exper-
imental excitation functions of both isotopes were ac-
curately determined and compared with the results of
three nuclear reaction codes. The agreement with the
theoretical results and the present experiments was dis-
cussed for each isotope separately, because the different
codes gave different quality estimations in the case of
the above three radioisotopes. From the measured ex-
citation functions yield curves were also calculated in
the investigated energy range. Since both samarium iso-
topes are important for medical applications, a compari-
son was also made between all possible routes. It turned
out, as expected, that the neutron induced production in
reactors is the most economical way for mass produc-
tion of these isotope in carrier added form. However, it
should be mentioned that for no carrier added end prod-
uct and small scale or research production charged par-
ticle induced reactions can be used as an alternative.
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